1. Home
  2. WNC vs KALA Comparison

WNC vs KALA Comparison

Compare WNC & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WNC

Wabash National Corporation

HOLD

Current Price

$9.12

Market Cap

392.2M

Sector

Industrials

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.22

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNC
KALA
Founded
1985
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.2M
319.6M
IPO Year
2009
2017

Fundamental Metrics

Financial Performance
Metric
WNC
KALA
Price
$9.12
$0.22
Analyst Decision
Hold
Buy
Analyst Count
1
3
Target Price
$11.00
$31.50
AVG Volume (30 Days)
468.5K
2.9M
Earning Date
05-01-2026
05-13-2026
Dividend Yield
3.50%
N/A
EPS Growth
179.22
41.50
EPS
5.07
N/A
Revenue
$2,027,489,000.00
N/A
Revenue This Year
$10.65
N/A
Revenue Next Year
$14.06
N/A
P/E Ratio
$1.80
N/A
Revenue Growth
8.81
N/A
52 Week Low
$6.78
$0.15
52 Week High
$12.94
$20.58

Technical Indicators

Market Signals
Indicator
WNC
KALA
Relative Strength Index (RSI) 52.63 44.24
Support Level $8.58 $0.15
Resistance Level $9.33 $0.72
Average True Range (ATR) 0.37 0.02
MACD 0.15 0.01
Stochastic Oscillator 77.52 75.61

Price Performance

Historical Comparison
WNC
KALA

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: